And the reason the market puts little value on this technology is ...?
Please don't say because the market is correcting. Biotechs with great new drugs or diagnostics go up big almost every day. Something is missing here. I offered 2 possible reasons, lack of faith current management can be successful or many years before this is ready for the real world. Any other reasons you can think of?